![Bill Colone](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cargos activos de Bill Colone
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Singlepass, Inc.
![]() Singlepass, Inc. Medical SpecialtiesHealth Technology Singlepass, Inc. has developed a unique electrocautery device that improves the clinical outcomes of deep tissue biopsy procedures. The company is based in Lake Forest, CA. The patented, single-use device prevents and stops bleeding caused by tissue extraction by cauterizing the tissue channel. It is the only cautery device of its kind that can be used for biopsy procedures. Singlepass was founded by Peter Sunenshine and Kevin Hirsch. The CEO is Bill Colone. | Director Ejecutivo | - | - |
Historial de carrera de Bill Colone
Antiguos cargos conocidos de Bill Colone.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
UroDev Medical
![]() UroDev Medical Medical SpecialtiesHealth Technology UroDev Medical develops a urinary catheter that allows the patient to control the flow of urine by actuating a magnetic valve. The company was founded by Zach Mckinney and Derek Herrera in 2015 and is headquartered in San Clemente, CA. | Director Ejecutivo | - | - |
Estadísticas
Internacional
Estados Unidos | 3 |
Operativa
Chief Executive Officer | 2 |
Sectorial
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
UroDev Medical
![]() UroDev Medical Medical SpecialtiesHealth Technology UroDev Medical develops a urinary catheter that allows the patient to control the flow of urine by actuating a magnetic valve. The company was founded by Zach Mckinney and Derek Herrera in 2015 and is headquartered in San Clemente, CA. | Health Technology |
Singlepass, Inc.
![]() Singlepass, Inc. Medical SpecialtiesHealth Technology Singlepass, Inc. has developed a unique electrocautery device that improves the clinical outcomes of deep tissue biopsy procedures. The company is based in Lake Forest, CA. The patented, single-use device prevents and stops bleeding caused by tissue extraction by cauterizing the tissue channel. It is the only cautery device of its kind that can be used for biopsy procedures. Singlepass was founded by Peter Sunenshine and Kevin Hirsch. The CEO is Bill Colone. | Health Technology |
- Bolsa de valores
- Insiders
- Bill Colone
- Experiencia